Patrick Melvin joins oncology leadership team at INC Research

Tuesday, March 1, 2011 08:00 AM

CRO INC Research has named Patrick Melvin executive director, Oncology. He will be using his hematology/oncology trial experience for phase I first-in-man studies through pivotal global phase IV programs.

Melvin has nearly 20 years of experience in clinical drug development in hematology and oncology. He previously worked in operations, strategic planning and corporate development within the oncology business of both PPD and Premier Research. His key early-phase experience includes multiple variations of early-phase hematology/oncology trial designs, while his later-phase experience includes pivotal trial experience in the U.S., Western and Eastern Europe, Latin America and Asia-Pacific.

Share:          
CWWeekly

January 26

2015 CRO outlook: M&As, IPOs, strategic partnerships and increased eClinical outsourcing expected to continue

IOM, industry stakeholders propose standards, guidelines for open sharing of clinical trial data

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January

All eyes on EMA’s adaptive licensing pilot
Sponsors could offer innovative drugs to patients 8 years sooner

Ice Bucket Challenge a boon for ALS research
Donations soar, but phenomenon difficult to replicate

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

December

Growing adoption of feasibility review committees
Early reports cite fewer amendments, improved cycle time

AMCs vying to better compete for industry trials
Working to conquer study start-up delays, IRB review process

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs